Formation Bio
11 known investors
Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.
Founders & leadership
BL
Ben LiuCEO & Co-Founder
LZ
Linhao ZhangCo-Founder
Investors · 11
Sequoia Capital✓ verifiedMenlo Park · $4.4M – $214M
Section 32✓ verifiedPalo Alto
Thrive Capital✓ verifiedNew York · $500K – $25M
Andreessen HorowitzMenlo Park · $500K – $50M
Felicis VenturesSan Francisco · $500K – $15M
FPVJackson · $100K – $5M
Hyphen CapitalSan Francisco
SV AngelSan Francisco
Tq Ventures LlcNew York
Dragoneer Investment GroupreportedSan Francisco · $100K – $5M
Sound VenturesreportedSanta Monicavia Ashton Kutcher · inferred
In the news
- This Sam Altman-Backed $1.8 Billion Startup Bets AI Can Get Drugs Through Clinical Trials Fasterforbes.com · 2026
- Mobly Secures $2.5 Million Seed Round to Transform Lead Capture and Qualification in B2B | Presidio Legalpresidio.legal · 2024
- Sanofi-backed Formation Bio raises $372 million in late-stage funding round | Reutersreuters.com · 2024
- Formation Bio secures $372MM Series D funding to grow drug pipeline and continue expanding AI-driven drug development platformprnewswire.com · 2024
- Formation Bio raises $372M to boost drug development with AI | TechCrunchtechcrunch.com · 2024